The article Should more Ashkenazi Jews Use Test For Cancer Gene? Doctors are Split (Foward Newspaper, March 20th 2015) by Karen Tucks shows a new initiative offering subsidized screening for cancer-causing mutations in Ashenazi Jews. The program, led by Susan Klugman, medical director of PJGH, will offer screenings for mutations in the BRCA1 and BRCA2 genes for just $100 and will even test for those who are considered “low-risk” for a mutation. The PJGH initiative is the first of its kind in the United States to provide affordable screenings for those who are low-risk and typically not covered by insurance for this kind of testing.
Rabin Medical Center is in full support of cancer research and genetic testing for the BRCA gene. Since early detection is currently the best tools for survival among this high risk population, the Rabin Medical Center has established the ONLY special clinic in Israel to perform this testing to lead to the treatment and prevention of cancer. The BRCA Multidisciplinary Clinic was founded to serve patients with a high risk of cancer at Rabin Medical Center’s Davidoff Cancer Center—a world class facility whose sole focus is on the treatment and prevention of cancer. The results of this genetic test make a significant difference in the lives of people at high risk for cancer.
The American Friends of Rabin Medical Center is proud to host our fifth annual Cheryl Diamond NYC 5K Schelp Walk on Sunday, June 21st 2015 in support of Breast and Ovarian Cancer. Breast and ovarian cancers are the most common cancers afflicting women in the United States and Israel. Throughout their lifetimes, one in seven women will be diagnosed with breast cancer and over 22,000 women will be diagnosed with ovarian cancer annually.
To make a donation to our BRCA clinic or to sign up for the NYC 5k Schlep Walk use the following link: